Academic Journals Database
Disseminating quality controlled scientific knowledge

No association of CDK5 genetic variants with Alzheimer's disease risk

ADD TO MY LIST
 
Author(s): Vázquez-Higuera José | Mateo Ignacio | Sánchez-Juan Pascual | Rodríguez-Rodríguez Eloy | Infante Jon | Berciano José | Combarros Onofre

Journal: BMC Medical Genetics
ISSN 1471-2350

Volume: 10;
Issue: 1;
Start page: 68;
Date: 2009;
Original page

ABSTRACT
Abstract Background As cyclin-dependent kinase 5 (CDK5) has been implicated in the abnormal hyperphosphorylation of tau in Alzheimer's disease (AD) brain, and the development of neurofibrillary tangles, we examined the contribution of this gene to the susceptibility for AD. Methods We examined genetic variations of CDK5 by genotyping haplotype tagging SNPs (htSNPs) (rs9278, rs2069459, rs891507, rs2069454, rs1549759 and rs2069442) in a group of 408 Spanish AD cases and 444 controls. Results There were no differences in the genotypic, allelic or haplotypic distributions between cases and controls in the overall analysis or after stratification by APOE ε4 allele. Conclusion Our negative findings in the Spanish population argue against the hypothesis that CDK5 genetic variations are causally related to AD risk. Still, additional studies using different sets of patients and control subjects deserve further attention, since supporting evidence for association between CDK5 gene and AD risk in the Dutch population exists.
Affiliate Program     

Tango Rapperswil
Tango Rapperswil